Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 186

1.

The broad clinical phenotype of Type 1 diabetes at presentation.

Merger SR, Leslie RD, Boehm BO.

Diabet Med. 2013 Feb;30(2):170-8. doi: 10.1111/dme.12048. Review.

PMID:
23075321
2.

Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2beta predict immune-mediated (Type 1) diabetes in relatives.

Maclaren N, Lan M, Coutant R, Schatz D, Silverstein J, Muir A, Clare-Salzer M, She JX, Malone J, Crockett S, Schwartz S, Quattrin T, DeSilva M, Vander Vegt P, Notkins A, Krischer J.

J Autoimmun. 1999 Jun;12(4):279-87.

PMID:
10330299
3.

Correlations between islet autoantibody specificity and the SLC30A8 genotype with HLA-DQB1 and metabolic control in new onset type 1 diabetes.

Brorsson C, Vaziri-Sani F, Bergholdt R, Eising S, Nilsson A, Svensson J, Lernmark Å, Pociot F; Danish Study Group of Childhood Diabetes.

Autoimmunity. 2011 Mar;44(2):107-14. doi: 10.3109/08916934.2010.509120. Epub 2010 Sep 14.

PMID:
20836749
4.

The three ZNT8 autoantibody variants together improve the diagnostic sensitivity of childhood and adolescent type 1 diabetes.

Andersson C, Larsson K, Vaziri-Sani F, Lynch K, Carlsson A, Cedervall E, Jönsson B, Neiderud J, Månsson M, Nilsson A, Lernmark A, Elding Larsson H, Ivarsson SA.

Autoimmunity. 2011 Aug;44(5):394-405. doi: 10.3109/08916934.2010.540604. Epub 2011 Jan 19.

PMID:
21244337
5.

Autoantibody negative new onset type 1 diabetic patients lacking high risk HLA alleles in a caucasian population: are these type 1b diabetes cases?

Tiberti C, Buzzetti R, Anastasi E, Dotta F, Vasta M, Petrone A, Cervoni M, Torresi P, Vecci E, Multari G, Di Mario U.

Diabetes Metab Res Rev. 2000 Jan-Feb;16(1):8-14.

PMID:
10707033
6.

Islet autoantibodies in Latvian subjects with non-insulin-dependent diabetes mellitus: slow-onset type 1 diabetes or polyendocrine autoimmunity?

Shtauvere-Brameus A, Falorni A, Rumba I, Sanjeevi CB.

Ann N Y Acad Sci. 2002 Apr;958:259-62.

PMID:
12021119
7.

Immunological heterogeneity in type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease.

Seissler J, de Sonnaville JJ, Morgenthaler NG, Steinbrenner H, Glawe D, Khoo-Morgenthaler UY, Lan MS, Notkins AL, Heine RJ, Scherbaum WA.

Diabetologia. 1998 Aug;41(8):891-7.

PMID:
9726590
8.

Progression to insulin-requiring diabetes in seronegative prediabetic subjects: the role of two HLA-DQ high-risk haplotypes.

Pietropaolo M, Becker DJ, LaPorte RE, Dorman JS, Riboni S, Rudert WA, Mazumdar S, Trucco M.

Diabetologia. 2002 Jan;45(1):66-76.

PMID:
11845225
9.

Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.

Whittingham S, Byron SL, Tuomilehto J, Zimmet PZ, Myers MA, Vidgren G, Rowley MJ, Feeney SJ, Koskela P, Tuomilehto-Wolf E, Mackay IR.

Diabet Med. 1997 Aug;14(8):678-85.

PMID:
9272595
10.

Autoantibodies to a 38-kDa glycosylated islet cell membrane-associated antigen in (pre)type 1 diabetes: association with IA-2 and islet cell autoantibodies.

Winnock F, Christie MR, Batstra MR, Aanstoot HJ, Weets I, Decochez K, Jopart P, Nicolaij D, Gorus FK; Belgian Diabetes Registry.

Diabetes Care. 2001 Jul;24(7):1181-6.

PMID:
11423499
11.

Triple specificity of ZnT8 autoantibodies in relation to HLA and other islet autoantibodies in childhood and adolescent type 1 diabetes.

Andersson C, Vaziri-Sani F, Delli A, Lindblad B, Carlsson A, Forsander G, Ludvigsson J, Marcus C, Samuelsson U, Ivarsson S, Lernmark A, Larsson HE; BDD Study Group.

Pediatr Diabetes. 2013 Mar;14(2):97-105. doi: 10.1111/j.1399-5448.2012.00916.x. Epub 2012 Sep 10.

PMID:
22957668
12.

Altered natural killer (NK) cell frequency and phenotype in latent autoimmune diabetes in adults (LADA) prior to insulin deficiency.

Akesson C, Uvebrant K, Oderup C, Lynch K, Harris RA, Lernmark A, Agardh CD, Cilio CM.

Clin Exp Immunol. 2010 Jul 1;161(1):48-56. doi: 10.1111/j.1365-2249.2010.04114.x. Epub 2010 Apr 9.

13.

Beta-cell autoantibodies in children with type 2 diabetes mellitus: subgroup or misclassification?

Reinehr T, Schober E, Wiegand S, Thon A, Holl R; DPV-Wiss Study Group.

Arch Dis Child. 2006 Jun;91(6):473-7. Epub 2006 Jan 31.

14.

Glutamic acid decarboxylase and ICA512/IA-2 autoantibodies as disease markers and relationship to residual beta-cell function and glycemic control in young type 1 diabetic patients.

Zanone MM, Catalfamo E, Pietropaolo SL, Rabbone I, Sacchetti C, Cerutti F, Trucco M, Cavallo-Perin P.

Metabolism. 2003 Jan;52(1):25-9.

PMID:
12524658
15.
16.

Genetic, autoimmune, and clinical characteristics of childhood- and adult-onset type 1 diabetes.

Sabbah E, Savola K, Ebeling T, Kulmala P, Vähäsalo P, Ilonen J, Salmela PI, Knip M.

Diabetes Care. 2000 Sep;23(9):1326-32.

17.

Glucose tolerance and beta-cell function in islet autoantibody-positive children recruited to a secondary prevention study.

Andersson C, Carlsson A, Cilio C, Cedervall E, Ivarsson SA, Jonsdottir B, Jönsson B, Larsson K, Neiderud J, Lernmark A, Elding Larsson H; DiAPREV-IT Study Group.

Pediatr Diabetes. 2013 Aug;14(5):341-9. doi: 10.1111/pedi.12023. Epub 2013 Mar 8.

PMID:
23469940
18.
19.

Glutamic acid decarboxylase 65 and islet cell antigen 512/IA-2 autoantibodies in relation to human leukocyte antigen class II DR and DQ alleles and haplotypes in type 1 diabetes mellitus.

Stayoussef M, Benmansour J, Al-Jenaidi FA, Said HB, Rayana CB, Mahjoub T, Almawi WY.

Clin Vaccine Immunol. 2011 Jun;18(6):990-3. doi: 10.1128/CVI.00073-11. Epub 2011 Apr 13.

20.

Cytotoxic T lymphocyte antigen 4 gene polymorphism confers susceptibility to type 1 diabetes in Japanese children: analysis of association with HLA genotypes and autoantibodies.

Kikuoka N, Sugihara S, Yanagawa T, Ikezaki A, Kim HS, Matsuoka H, Kobayashi Y, Wataki K, Konda S, Sato H, Miyamoto S, Sasaki N, Sakamaki T, Niimi H, Murata M.

Clin Endocrinol (Oxf). 2001 Nov;55(5):597-603.

PMID:
11894970

Supplemental Content

Support Center